Details for Patent: 8,461,187
✉ Email this page to a colleague
Which drugs does patent 8,461,187 protect, and when does it expire?
Patent 8,461,187 protects DEXILANT and DEXILANT SOLUTAB and is included in two NDAs.
Protection for DEXILANT has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has eight patent family members in five countries.
Summary for Patent: 8,461,187
| Title: | Multiple PPI dosage form |
| Abstract: | Herein provided are dosage forms (variously referred to as “formulations”) comprising a PPI that is released from the dosage form as a first and a second dose. Each dose of PPI is present in an amount sufficient to raise the plasma levels of the PPI to at least 100 ng/ml. |
| Inventor(s): | Rajneesh Taneja, Majid Vakilynejad |
| Assignee: | Takeda Pharmaceuticals USA Inc |
| Application Number: | US11/629,016 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,461,187 |
|
Patent Claim Types: see list of patent claims | Use; Dosage form; |
Drugs Protected by US Patent 8,461,187
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Takeda Pharms Usa | DEXILANT | dexlansoprazole | CAPSULE, DELAYED RELEASE;ORAL | 022287-001 | Jan 30, 2009 | AB | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Takeda Pharms Usa | DEXILANT | dexlansoprazole | CAPSULE, DELAYED RELEASE;ORAL | 022287-002 | Jan 30, 2009 | AB | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Takeda Pharms Usa | DEXILANT SOLUTAB | dexlansoprazole | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL | 208056-001 | Jan 26, 2016 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,461,187
| PCT Information | |||
| PCT Filed | June 01, 2005 | PCT Application Number: | PCT/US2005/019028 |
| PCT Publication Date: | January 26, 2006 | PCT Publication Number: | WO2006/009602 |
International Family Members for US Patent 8,461,187
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2005264864 | ⤷ Start Trial | |||
| Canada | 2570916 | ⤷ Start Trial | |||
| European Patent Office | 1768668 | ⤷ Start Trial | |||
| Japan | 2008503455 | ⤷ Start Trial | |||
| Japan | 2014193888 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
